Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants
- 23 August 2013
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 31, D52-D57
- https://doi.org/10.1016/j.vaccine.2013.02.029
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000The Lancet, 2012
- Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trialCMAJ : Canadian Medical Association Journal, 2012
- The Burden of Invasive Early-onset Neonatal Sepsis in the United States, 2005–2008The Pediatric Infectious Disease Journal, 2011
- Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births: A Retrospective Cohort StudyPLoS Medicine, 2011
- Serotype Distribution and Invasive Potential of Group B Streptococcus Isolates Causing Disease in Infants and Colonizing Maternal-Newborn DyadsPLOS ONE, 2011
- Where Do Poor Women in Developing Countries Give Birth? A Multi-Country Analysis of Demographic and Health Survey DataPLOS ONE, 2011
- Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trialThe Lancet, 2009
- Group B Streptococcus and Early-Onset Sepsis in the Era of Maternal ProphylaxisPediatric Clinics of North America, 2009
- Vaccines: Correlates of Vaccine‐Induced ImmunityClinical Infectious Diseases, 2008
- Invasive Group B Streptococcal Infection in Infants, MalawiEmerging Infectious Diseases, 2007